Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review

  • ID: 1292013
  • SWOT Analysis
  • 84 pages
  • GlobalData
  • Bayer AG
1 of 5

FEATURED COMPANIES

  • Allergan Plc
  • BASF SE
  • GlaxoSmithKline Plc
  • Heska Corp
  • Huntsman Corp
  • Johnson & Johnson
  • MORE
Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Bayer AG (Bayer) carries out the research, development, production and commercialization of products in the areas of human and animal health care, and agriculture. It provides pharmaceuticals for cardiology, women’s healthcare, cancer, hematology, ophthalmologyand other indications. The company's product portfolio includes prescription products, specialty therapeutics, animal health care products, diagnostic imaging equipment, nonprescription (over-the-counter - OTC) products, seeds, crop protection solutions and nonagricultural pest control solutions. Bayer markets its healthcare and crop protection products principally through wholesalers, pharmacies, hospitals and retailers. It operates through a network of subsidiaries in Asia-Pacific, Europe, the US, Latin America, Africa and the Middle East. Bayer is headquartered in Leverkusen, Germany.

Bayer AG Key Recent Developments

Apr 05, 2018: Bayer to Showcase Data from Diverse Oncology Pipeline at AACR 2018
Mar 28, 2018: Life Science Leaders Gather at Medidata NEXT Basel and Frankfurt to Examine New Opportunities to Improve Clinical Development and Better Patient Lives
Mar 27, 2018: Bayer partners with Plug and Play To Address the Rapid Changes in Healthcare
Mar 06, 2018: Travelers Partners with Cedars-Sinai, Samsung Electronics America, Bayer and appliedVR to Test Digital Tools in Treatment of Acute Orthopaedic Injuries
Feb 16, 2018: Ten years of Bayer support for employees’ volunteering work

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Allergan Plc
  • BASF SE
  • GlaxoSmithKline Plc
  • Heska Corp
  • Huntsman Corp
  • Johnson & Johnson
  • MORE
Section 1 - About the Company
  • Bayer AG - Key Facts
  • Bayer AG - Key Employees
  • Bayer AG - Key Employee Biographies
  • Bayer AG - Major Products and Services
  • Bayer AG - History
  • Bayer AG - Company Statement
  • Bayer AG - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Bayer AG - Business Description
  • Business Segment: All Other Segments
  • Overview
  • Performance
  • Business Segment: Animal Health
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Consumer Health
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Crop Science
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Pharmaceuticals
  • Overview
  • Performance
  • Key Stats
  • Geographical Segment: Asia Pacific
  • Performance
  • Geographical Segment: Europe, Middle East and Africa
  • Performance
  • Geographical Segment: Latin America
  • Performance
  • Geographical Segment: North America
  • Performance
  • R&D Overview
  • Bayer AG - Corporate Strategy
  • Bayer AG - SWOT Analysis
  • SWOT Analysis - Overview
  • Bayer AG - Strengths
  • Bayer AG - Weaknesses
  • Bayer AG - Opportunities
  • Bayer AG - Threats
  • Bayer AG - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences, Power Financial Deals and Alliances
  • Bayer AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Bayer AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Bayer AG, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Apr 05, 2018: Bayer to Showcase Data from Diverse Oncology Pipeline at AACR 2018
  • Apr 05, 2018: Bayer to Showcase Data from Diverse Oncology Pipeline at AACR 2018
  • Mar 28, 2018: Life Science Leaders Gather at Medidata NEXT Basel and Frankfurt to Examine New Opportunities to Improve Clinical Development and Better Patient Lives
  • Mar 27, 2018: Bayer partners with Plug and Play To Address the Rapid Changes in Healthcare
  • Mar 06, 2018: Travelers Partners with Cedars-Sinai, Samsung Electronics America, Bayer and appliedVR to Test Digital Tools in Treatment of Acute Orthopaedic Injuries
  • Feb 16, 2018: Ten years of Bayer support for employees’ volunteering work
  • Dec 09, 2017: New Therapies Improve Outlook for Bleeding and Clotting Disorders
  • Dec 04, 2017: NUST MISIS Students Develop an App for Patients with Bronchiectasis
  • Dec 01, 2017: Bayer invests in differentiated drug pipeline with over 50 projects focused on high unmet medical needs
  • Nov 30, 2017: Bayer combines pharmaceutical research and development unit
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Bayer AG, Key Facts
  • Bayer AG, Key Employees
  • Bayer AG, Key Employee Biographies
  • Bayer AG, Major Products and Services
  • Bayer AG, History
  • Bayer AG, Subsidiaries
  • Bayer AG, Joint Venture
  • Bayer AG, Key Competitors
  • Bayer AG, Ratios based on current share price
  • Bayer AG, Annual Ratios
  • Bayer AG, Annual Ratios
  • Bayer AG, Annual Ratios
  • Bayer AG, Interim Ratios
  • Bayer AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Bayer AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Bayer AG, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Bayer AG, Performance Chart (2013 - 2017)
  • Bayer AG, Ratio Charts
  • Bayer AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Bayer AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Pfizer Inc
  • Novartis AG
  • Mitsubishi Chemical Corporation
  • Johnson & Johnson
  • Huntsman Corp
  • Heska Corp
  • GlaxoSmithKline Plc
  • BASF SE
  • Allergan Plc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll